A disease- and phosphorylation-related nonmechanical function for keratin 8

Journal of Cell Biology

Volumn 174, Issue 1, 2006, Pages 115-125

  Ku, Nam On ^a   Omary, M Bishr ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CYSTINE; FAS ANTIBODY; GLYCINE; KERATIN; MUTANT PROTEIN; PROTEIN KERATIN 18; PROTEIN KERATIN 8; SERINE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; LIVER INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; FAS LIGAND PROTEIN; GENETIC PREDISPOSITION TO DISEASE; HEPATOCYTES; HUMANS; INTERMEDIATE FILAMENT PROTEINS; KERATIN-8; KERATINS; LIVER DISEASES; LIVER FUNCTION TESTS; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MICROCYSTINS; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; PEPTIDES, CYCLIC; PHOSPHORYLATION; TUMOR NECROSIS FACTORS; VARIATION (GENETICS);

MUS MUSCULUS;

EID: 33745628320     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.200602146     Document Type: Article

References (58)

1. Baines, C.P., and J.D. Molkentin. 2005. STRESS signaling pathways that modulate cardiac myocyte apoptosis. J. Mol. Cell. Cardiol. 38:47-62.
2. Baribault, H., J. Penner, R.V. Iozzo, and M. Wilson-Heiner. 1994. Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice. Genes Dev. 8:2964-2973.
3. Behrens, A., M. Sibilia, and E.F. Wagner. 1999. Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nat. Genet. 21:326-329.
4. Casanova, M.L., A. Bravo, A. Ramirez, G. Morreale de Escobar, F. Were, G. Merlino, M. Vidal, and J.L. Jorcano. 1999. Exocrine pancreatic disorders in transgenic mice expressing human keratin 8. J. Clin. Invest. 103:1587-1595.
5. Caulin, C., C.F. Ware, T.M. Magin, and R.G. Oshima. 2000. Keratin-dependent, epithelial resistance to tumor necrosis factor-induced apoptosis. J. Cell Biol. 149:17-22.
6. Coulombe, P.A., and M.B. Omary. 2002. "Hard" and "soft" principles defining the structure, function and regulation of keratin intermediate filaments. Curr. Opin. Cell Biol. 14:110-122.
7. Deak, M., A.D. Clifton, L.M. Lucocq, and D.R. Alessi. 1998. Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J. 17:4426-4441.
8. Fuchs, E., and K. Weber. 1994. Intermediate filaments: structure, dynamics, function, and disease. Annu. Rev. Biochem. 63:345-382.
9. Fuchs, E., and D.W. Cleveland. 1998. A structural scaffolding of intermediate filaments in health and disease. Science. 279:514-519.
10. Gallo, K.A., and G.L. Johnson. 2002. Mixed-lineage kinase control of JNK and p38 MAPK pathways. Nat. Rev. Mol. Cell Biol. 3:663-672.
11. Gilbert, S., A. Loranger, N. Daigle, and N. Marceau. 2001. Simple epithelium keratins 8 and 18 provide resistance to Fas-mediated apoptosis. The protection occurs through a receptor-targeting modulation. J. Cell Biol. 154:763-773.
12. Gilbert, S., A. Loranger, and N. Marceau. 2004. Keratins modulate c-Flip/extracellular signal-regulated kinase 1 and 2 antiapoptotic signaling in simple epithelial cells. Mol. Cell. Biol. 24:7072-7081.
13. He, T., A. Stepulak, T.H. Holmstrom, M.B. Omary, and J.E. Eriksson. 2002. The intermediate filament protein keratin 8 is a novel cytoplasmic substrate for c-Jun N-terminal kinase. J. Biol. Chem. 277:10767-10774.
14. Herrmann, H., and U. Aebi. 2004. Intermediate filaments: molecular structure, assembly mechanism, and integration into functionally distinct intracellular scaffolds. Annu. Rev. Biochem. 73:749-789.
15. Hess, J., P. Angel, and M. Schorpp-Kistner. 2004. AP-1 subunits: quarrel and harmony among siblings. J. Cell Sci. 117:5965-5973.
16. Holzenberger, M., J. Dupont, B. Ducos, P. Leneuve, A. Geloen, P.C. Even, P. Cervera, and Y. Le Bouc. 2003. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature. 421:182-187.
17. Impey, S., S.R. McCorkle, H. Cha-Molstad, J.M. Dwyer, G.S. Yochum, J.M. Boss, S. McWeeney, J.J. Dunn, G. Mandel, and R.H. Goodman. 2004. Defining the CREB regulon: a genome-wide analysis of transcription factor regulatory regions. Cell. 119:1041-1054.
18. Kaplowitz, N. 2002. Biochemical and cellular mechanisms of toxic liver injury. Semin. Liver Dis. 22:137-144.
19. Krauss, S., and W.W. Franke. 1990. Organization and sequence of the human gene encoding cytokeratin 8. Gene. 86:241-249.
20. Ku, N.O., S. Michie, R.G. Oshima, and M.B. Omary. 1995. Chronic hepatitis, hepatocyte fragility, and increased soluble phosphoglycokeratins in transgenic mice expressing a keratin 18 conserved arginine mutant. J. Cell Biol. 131:1303-1314.
21. Ku, N.O., S.A. Michie, R.M. Soetikno, E.Z. Resurreccion, R.L. Broome, R.G. Oshima, and M.B. Omary. 1996. Susceptibility to hepatotoxicity in transgenic mice that express a dominant-negative human keratin 18 mutant. J. Clin. Invest. 98:1034-1046.
22. Ku, N.O., T.L. Wright, N.A. Terrault, R. Gish, and M.B. Omary. 1997. Mutation of human keratin 18 in association with cryptogenic cirrhosis. J. Clin. Invest. 99:19-23.
23. Ku, N.O., S.A. Michie, R.M. Soetikno, E.Z. Resurreccion, R.L. Broome, and M.B. Omary. 1998. Mutation of a major keratin phosphorylation site predisposes to hepatotoxic injury in transgenic mice. J. Cell Biol. 143:2023-2032.
24. Ku, N.O., X. Zhou, D.M. Toivola, and M.B. Omary. 1999. The cytoskeleton of digestive epithelia in health and disease. Am. J. Physiol. 277:G1108-G1137.
25. Ku, N.O., R. Gish, T.L. Wright, and M.B. Omary. 2001. Keratin 8 mutations in patients with cryptogenic liver disease. N. Engl. J. Med. 344:1580-1587.
26. Ku, N.O., S. Azhar, and M.B. Omary. 2002. Keratin 8 phosphorylation by p38 kinase regulates cellular keratin filament reorganization: modulation by a keratin 1-like disease causing mutation. J. Biol. Chem. 277:10775-10782.
27. Ku, N.O., R.M. Soetikno, and M.B. Omary. 2003. Keratin mutation in transgenic mice predisposes to Fas but not TNF-induced apoptosis and massive liver injury. Hepatology. 37:1006-1014.
28. Ku, N.O., D.M. Toivola, Q. Zhou, G.Z. Tao, B. Zhong, and M.B. Omary. 2004. Studying simple epithelial keratins in cells and tissues. Methods Cell Biol. 78:489-517.
29. Ku, N.O., J.K. Lim, S.M. Krams, C.O. Esquivel, E.B. Keeffe, T.L. Wright, D.A. Parry, and M.B. Omary. 2005. Keratins as susceptibility genes for end-stage liver disease. Gastroenterology. 129:885-893.
30. Lai, Y.K., W.C. Lee, and K.D. Chen. 1993. Vimentin serves as a phosphate sink during the apparent activation of protein kinases by okadaic acid in mammalian cells. J. Cell. Biochem. 53:161-168.
31. Liao, J., N.O. Ku, and M.B. Omary. 1997. Stress, apoptosis, and mitosis induce phosphorylation of human keratin 8 at Ser-73 in tissues and cultured cells. J. Biol. Chem. 272:17565-17573.
32. Liu, J., and A. Lin. 2005. Role of JNK activation in apoptosis: a double-edged sword. Cell Res. 15:36-42.
33. Lobsiger, C.S., M.L. Garcia, C.M. Ward, and D.W. Cleveland. 2005. Altered axonal architecture by removal of the heavily phosphorylated neurofilament tail domains strongly slows superoxide dismutase 1 mutant-mediated ALS. Proc. Natl. Acad. Sci. USA. 102:10351-10356.
34. Loranger, A., S. Duclos, A. Grenier, J. Price, M. Wilson-Heiner, H. Baribault, and N. Marceau. 1997. Simple epithelium keratins are required for maintenance of hepatocyte integrity. Am. J. Pathol. 151:1673-1683.
35. Magin, T.M., R. Schroder, S. Leitgeb, F. Wanninger, K. Zatloukal, C. Grund, and D.W. Melton. 1998. Lessons from keratin 18 knockout mice: formation of novel keratin filaments, secondary loss of keratin 7 and accumulation of liver-specific keratin 8-positive aggregates. J. Cell Biol. 140:1441-1451.
36. Magin, T.M., J. Reichelt, and M. Hatzfeld. 2004. Emerging functions: diseases and animal models reshape our view of the cytoskeleton. Exp. Cell Res. 301:91-102.
37. Marceau, N., A. Loranger, S. Gilbert, N. Daigle, and S. Champetier. 2001. Keratin-mediated resistance to stress and apoptosis in simple epithelial cells in relation to health and disease. Biochem. Cell Biol. 79:543-555.
38. Moll, R., W.W. Franke, D.L. Schiller, B. Geiger, and R. Krepler. 1982. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell. 31:11-24.
39. Nguyen, M.D., R.C. Lariviere, and J.P. Julien. 2001. Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. Neuron. 30:135-147.
40. Omary, M.B., N.O. Ku, J. Liao, and D. Price. 1998. Keratin modifications and solubility properties in epithelial cells and in vitro. Subcell. Biochem. 31:105-140.
41. Omary, M.B., N.O. Ku, and D.M. Toivola. 2002. Keratins: guardians of the liver. Hepatology. 35:251-257.
42. Omary, M.B., P.A. Coulombe, and W.H. McLean. 2004. Intermediate filament proteins and their associated diseases. N. Engl. J. Med. 351:2087-2100.
43. Owens, D.W., N.J. Wilson, A.J. Hill, E.L. Rugg, R.M. Porter, A.M. Hutcheson, R.A. Quinlan, D. Van Heel, M. Parkes, D.P. Jewell, et al. 2004. Human keratin 8 mutations that disturb filament assembly observed in inflammatory bowel disease patients. J. Cell Sci. 117:1989-1999.
44. Pastorino, J.G., N. Shulga, and J.B. Hoek. 2003. TNF-alpha-induced cell death in ethanol-exposed cells depends on p38 MAPK signaling but is independent of Bid and caspase-8. Am. J. Physiol. Gastrointest. Liver Physiol. 285:G503-G516.
45. Porter, R.M., and E.B. Lane. 2003. Phenotypes, genotypes and their contribution to understanding keratin function. Trends Genet. 19:278-285.
46. Reinehr, R., S. Becker, A. Eberle, S. Grether-Beck, and D. Haussinger. 2005. Involvement of NADPH oxidase isoforms and Src family kinases in CD95-dependent hepatocyte apoptosis. J. Biol. Chem. 280:27179-27194.
47. Roux, P.P., and J. Blenis. 2004. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol. Mol. Biol. Rev. 68:320-344.
48. Sato, T., T. Machida, S. Takahashi, S. Iyama, Y. Sato, K. Kuribayashi, K. Takada, T. Oku, Y. Kawano, T. Okamoto, et al. 2004. Fas-mediated apoptosome formation is dependent on reactive oxygen species derived from mitochondrial permeability transition in Jurkat cells. J. Immunol. 173:285-296.
49. Strnad, P., T.C. Lienau, G.Z. Tao, L.C. Lazzeroni, F. Stickel, D. Schuppan, and M.B. Omary. 2006a. Keratin variants associate with progression of fibrosis during chronic hepatitis C infection. Hepatology. 43:1354-1363.
50. Strnad, P., T.C. Lienau, G.Z. Tao, N.O. Ku, T.M. Magin, and M.B. Omary. 2006b. Denaturing temperature selection may underestimate keratin mutation detection by DHPLC. Hum. Mutat. 27:444-452.
51. Tao, G.Z., I. Nakamichi, N.O. Ku, J. Wang, M. Frolkis, X. Gong, W. Zhu, R. Pytela, and M.B. Omary. 2006. Bispecific and human disease-related anti-keratin rabbit monoclonal antibodies. Exp. Cell Res. 312:411-422.
52. Toivola, D.M., Q. Zhou, L.S. English, and M.B. Omary. 2002. Type II keratins are phosphorylated on a unique motif during stress and mitosis in tissues and cultured cells. Mol. Biol. Cell. 13:1857-1870.
53. Toivola, D.M., N.O. Ku, E.Z. Resurreccion, D.R. Nelson, T.L. Wright, and M.B. Omary. 2004. Keratin 8 and 18 hyperphosphorylation is a marker of progression of human liver disease. Hepatology. 40:459-466.
54. Toivola, D.M., G.Z. Tao, A. Habtezion, J. Liao, and M.B. Omary. 2005. Beyond cellular integrity: organelle-related and protein-targeting functions of intermediate filaments. Trends Cell Biol. 15:608-617.
55. Yang, D.D., C.Y. Kuan, A.J. Whitmarsh, M. Rincon, T.S. Zheng, R.J. Davis, P. Rakic, and R.A. Flavell. 1997. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature. 389:865-870.
56. Zatloukal, K., C. Stumptner, A. Fuchsbichler, P. Fickert, C. Lackner, M. Trauner, and H. Denk. 2004. The keratin cytoskeleton in liver diseases. J. Pathol. 204:367-376.
57. Zhong, B., Q. Zhou, D.M. Toivola, G.Z. Tao, E.Z. Resurreccion, and M.B. Omary. 2004. Organ-specific stress induces mouse pancreatic keratin overexpression in association with NF-κB activation. J. Cell Sci. 117:1709-1719.
58. Zhou, Q., X. Ji, L. Chen, H.B. Greenberg, S.C. Lu, and M.B. Omary. 2005. Keratin mutation primes mouse liver to oxidative injury. Hepatology. 41:517-525.